Genetically modified dendritic cells--a new, promising cancer treatment strategy?
about
Recent developments in renal cell cancer immunotherapy.Gene-modified bone marrow cell therapy for prostate cancer.Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer.Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents.
P2860
Genetically modified dendritic cells--a new, promising cancer treatment strategy?
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Genetically modified dendritic cells--a new, promising cancer treatment strategy?
@ast
Genetically modified dendritic cells--a new, promising cancer treatment strategy?
@en
type
label
Genetically modified dendritic cells--a new, promising cancer treatment strategy?
@ast
Genetically modified dendritic cells--a new, promising cancer treatment strategy?
@en
prefLabel
Genetically modified dendritic cells--a new, promising cancer treatment strategy?
@ast
Genetically modified dendritic cells--a new, promising cancer treatment strategy?
@en
P2093
P2860
P356
P1476
Genetically modified dendritic cells--a new, promising cancer treatment strategy?
@en
P2093
Grabarczyk P
Kowalczyk DW
Mackiewicz A
Mackiewicz-Wysocka M
Wysocki PJ
P2860
P304
P356
10.1517/14712598.2.8.835
P407
P577
2002-12-01T00:00:00Z